Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00686 |
| Species: | Homo sapiens |
| Position : | chr14:106152156-106153203 |
| Year: | 2024 |
| Title: | Core regions in immunoglobulin heavy chain enhancers essential for survival of non-Hodgkin lymphoma cells are identified by a CRISPR interference screen |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Burkitt lymphoma |
| PMID: | 38934080 |
| MONDO: | MONDO:0002483 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Human Burkitt lymphoma cell |
| CVCL ID: | |
| Cell Type: | Burkitt lymphoma cell |
| Cell Ontology ID: | CL:0000945 |
| Experiment Type: | Functional perturbation assay, Enhancer activity assay |
| High Throughput Method: | CRISPRi screening, RNA-seq, ATAC-seq |
| Low Throughput Method: | CRISPRi, RT-RT-qPCR, Western blot, Flow Cytometry, GFP competition assay |
| Target gene : | MYC |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00687 | chr14:106152156-106153203 | Blood | diffuse large B-cell lymphoma cell | diffuse large B-cell lymphoma |
| E_00865 | chr14:106152156-106153203 | Blood | Burkitt lymphoma cell | Burkitt lymphoma |
| E_00866 | chr14:106152156-106153203 | Blood | diffuse large B-cell lymphoma cell | diffuse large B-cell lymphoma |